...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM is October 5, 2016

Zenith filed a Notice of Meeting and Record Date document on August 4, 2016 announcing that their AGM will be on October 5, 2016....the same date as the Resverlogix AGM.

Share
New Message
Please login to post a reply